Hybrid operations safe for patients with iliofemoral peripheral artery disease: Study
Russian Federation: The findings of a new study conducted by Vladimir Starodubtsev and the team suggest the long-term safety and effectiveness of hybrid operations for individuals with iliofemoral peripheral arterial disease. The complete data of this study were published in the European Journal of Vascular and Endovascular Surgery.
Vascular surgeons face a dilemma when treating patients with combined iliac as well as common femoral artery (CFA) occlusive disease. Open surgical reconstruction (OR) or hybrid repair (HR) combining iliac stenting and femoral endarterectomy are the current recommendations. As a result, the goal of this randomized controlled study was to examine the short and midterm safety and effectiveness of hybrid repair and Open surgical reconstruction procedures for individuals with the co-existing iliac and common femoral occlusive disease.
The study was entered into the ClinicalTrials.gov database. Between 2015 and 2017, eligible patients with combined iliac and CFA occlusive disease were randomly assigned to either HR or OR. HR group patients had iliac artery recanalization and stenting, as well as CFA endarterectomy and patch angioplasty. The OR group received aortofemoral bypass surgery with concurrent CFA endarterectomy. Short-term (30-day) and mid-term (36-month) outcomes were compared across groups, including mortality, morbidity, and patency rates.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.